Merck KGaA CMD - Healthcare:R&D Update Call Transcript
Ladies and gentlemen, welcome to Merck's R&D Update Call 2020. (Operator Instructions)
May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Thank you, Abby. Dear, ladies and gentlemen, a very, very warm welcome to this R&D Update Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. And it's great to have all of you here joining this call, which is also the third deep dive session of last week's Capital Markets Day. And this is why I'd like to directly hand over to Amelie Schrader, Director, Investor Relations and Principal Healthcare Lead, to kick off this deep dive.
Thank you, Constantin. Dear, ladies and gentlemen, a very warm welcome also from my side. I kindly ask you to please turn to Page 3 of the slide deck for a brief introduction of the 4 representatives of our R&D and commercial leadership joining us
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |